Holen Sie sich die Stockscreener-App
9.335
2.82%
-0.245
Schlusskurs vom Vortag:
$9.58
Offen:
$9.3
24-Stunden-Volumen:
57,290
Relative Volume:
0.15
Marktkapitalisierung:
$609.23M
Einnahmen:
$512.35M
Nettoeinkommen (Verlust:
$-156.23M
KGV:
-3.7191
EPS:
-2.51
Netto-Cashflow:
$7.98M
1W Leistung:
-10.82%
1M Leistung:
-18.48%
6M Leistung:
+58.06%
1J Leistung:
+90.78%
1-Tages-Spanne:
$9.19
$9.45
1-Wochen-Bereich:
$9.19
$10.51
52-Wochen-Spanne:
$3.90
$14.38
Bioventus Inc Stock (BVS) Company Profile
Firmenname
Bioventus Inc
Sektor
Branche
Telefon
(919) 474-6700
Adresse
4721 EMPEROR BOULEVARD, SUITE 100, DURHAM
Vergleichen Sie BVS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BVS
Bioventus Inc
|
9.335 | 609.23M | 512.35M | -156.23M | 7.98M | -2.51 |
|
ABT
Abbott Laboratories
|
112.86 | 196.55B | 41.22B | 5.77B | 6.49B | 3.29 |
|
BSX
Boston Scientific Corp
|
95.33 | 141.03B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
366.39 | 139.65B | 21.97B | 3.59B | 3.21B | 9.33 |
|
MDT
Medtronic Plc
|
81.49 | 104.60B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
73.30 | 43.28B | 6.60B | 4.16B | 490.10M | 6.93 |
Bioventus Inc Stock (BVS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-17 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2023-12-07 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-08-09 | Hochstufung | Craig Hallum | Hold → Buy |
| 2022-11-22 | Herabstufung | Craig Hallum | Buy → Hold |
| 2022-11-09 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-11-09 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2022-03-15 | Eingeleitet | Craig Hallum | Buy |
| 2021-11-15 | Fortgesetzt | Morgan Stanley | Overweight |
| 2021-11-10 | Fortgesetzt | JP Morgan | Overweight |
| 2021-07-01 | Herabstufung | Goldman | Buy → Neutral |
| 2021-03-08 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-03-08 | Eingeleitet | Goldman | Buy |
| 2021-03-08 | Eingeleitet | JP Morgan | Overweight |
| 2021-03-08 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Bioventus Inc Aktie (BVS) Neueste Nachrichten
Where are the Opportunities in (BVS) - Stock Traders Daily
Bioventus CEO to Present at J.P. Morgan Healthcare Conference 2025 - StockTitan
Principal Financial Group Inc. Takes Position in Bioventus Inc. (NYSE:BVS) - Defense World
Bioventus Inc. (NYSE:BVS) Shares Acquired by Jane Street Group LLC - Defense World
Bioventus (NYSE:BVS) Trading Down 5.9%Here's Why - MarketBeat
Bioventus: Amply Rewarded For Recent Progress (NASDAQ:BVS) - Seeking Alpha
BVS Stock Gains Post Divestiture of Advanced Rehabilitation Business - MSN
Bioventus completes divestiture of its Advanced Rehabilitation business - Yahoo Finance
Bioventus stock Buy rating reaffirmed, focus shifts to Ultrasonics and international growth - Investing.com India
Bioventus Completes Divestiture of its Advanced Rehabilitation Business to Accelmed Partners - The Manila Times
Bioventus Completes $20M Advanced Rehabilitation Business Sale to Accelmed Partners - StockTitan
Bioventus Inc. (NYSE:BVS) Shares Acquired by Barclays PLC - Defense World
Bioventus Inc. (NYSE:BVS) Shares Purchased by Geode Capital Management LLC - Defense World
Franklin Resources Inc. Takes $1.01 Million Position in Bioventus Inc. (NYSE:BVS) - Defense World
Franklin Resources Inc. Makes New Investment in Bioventus Inc. (NYSE:BVS) - MarketBeat
Bioventus Inc. (NYSE:BVS) Stock Position Lifted by State Street Corp - MarketBeat
State Street Corp Has $8.08 Million Stock Holdings in Bioventus Inc. (NYSE:BVS) - Defense World
Bioventus SVP Anthony D'Adamio sells shares worth $61,579 By Investing.com - Investing.com Australia
Bioventus CFO Mark Leonard sells $113,018 in stock By Investing.com - Investing.com Australia
Bioventus CFO Mark Leonard sells $113,018 in stock - Investing.com India
Bioventus SVP Katrina Church sells $26,693 in stock By Investing.com - Investing.com Canada
Katrina J. Church Sells 2,535 Shares of Bioventus Inc. (NYSE:BVS) Stock - MarketBeat
Insider Selling: Bioventus Inc. (NYSE:BVS) CFO Sells $113,018.49 in Stock - MarketBeat
Bioventus SVP Anthony D’Adamio sells shares worth $61,579 By Investing.com - Investing.com Nigeria
Bioventus SVP Anthony D'Adamio sells shares worth $61,579 - Investing.com India
Bioventus SVP Katrina Church sells $26,693 in stock - Investing.com
Shareholder lawsuit ends with $15 million settlement - The Business Journals
Is Bioventus (BVS) Outperforming Other Medical Stocks This Year? - MSN
Medical Device Investors Get Final OK On $15M Deal - Law360
Bioventus Investors Get $15 Million Med Rebate Deal Approved - Bloomberg Law
Learn to Evaluate (BVS) using the Charts - Stock Traders Daily
Bioventus (NYSE:BVS) Upgraded to “Neutral” at JPMorgan Chase & Co. - Defense World
JP Morgan Upgrades Bioventus (BVS) - MSN
Bioventus (NYSE:BVS) Shares Gap UpHere's Why - MarketBeat
Bioventus (NYSE:BVS) Upgraded to Neutral at JPMorgan Chase & Co. - MarketBeat
Fmr LLC Acquires 166,014 Shares of Bioventus Inc. (NYSE:BVS) - Defense World
Fmr LLC Raises Position in Bioventus Inc. (NYSE:BVS) - MarketBeat
Bioventus Inc. (NYSE:BVS) Shares Acquired by Charles Schwab Investment Management Inc. - Defense World
Charles Schwab Investment Management Inc. Purchases 109,359 Shares of Bioventus Inc. (NYSE:BVS) - MarketBeat
Point72 Asset Management L.P. Makes New $788,000 Investment in Bioventus Inc. (NYSE:BVS) - MarketBeat
How to Take Advantage of moves in (BVS) - Stock Traders Daily
Jacobs Levy Equity Management Inc. Lowers Stake in Bioventus Inc. (NYSE:BVS) - MarketBeat
Wall Street Analysts Think Bioventus (BVS) Could Surge 26.03%: Read This Before Placing a Bet - Yahoo Finance
Joint Pain Injection Market Expected to Reach Prominent Growth - openPR
Bioventus Inc (BVS) Stock Price Down 3.98% on Dec 4 - GuruFocus.com
Trading (BVS) With Integrated Risk Controls - Stock Traders Daily
Osteoarthritis Therapeutics Market Size to Reach USD 24.34 Bn by 2034 - GlobeNewswire Inc.
Principal Financial Group Inc. Invests $210,000 in Bioventus Inc. (NYSE:BVS) - Defense World
Connor Clark & Lunn Investment Management Ltd. Buys Shares of 258,756 Bioventus Inc. (NYSE:BVS) - MarketBeat
Segall Bryant & Hamill LLC Invests $4.52 Million in Bioventus Inc. (NYSE:BVS) - MarketBeat
Bioventus (BVS) Matches Q3 Earnings Estimates - MSN
Finanzdaten der Bioventus Inc-Aktie (BVS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Bioventus Inc-Aktie (BVS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| CHURCH KATRINA J | SVP & Chief Compliance Officer |
Dec 23 '24 |
Sale |
10.53 |
2,535 |
26,694 |
47,264 |
| D'Adamio Anthony | SVP & General Counsel |
Dec 23 '24 |
Sale |
10.53 |
5,848 |
61,579 |
109,578 |
2.55%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):